When AI Needs to Move Faster Than Your Competitors
Build a 6-Month Speed Advantage Before Competitors Lock Your Top Accounts
Turn AI experimentation into a governed revenue system that withstands CFO scrutiny, scales safely, and accelerates time-to-market.
Most MedTech leaders are no longer asking whether AI matters. They are asking whether it is actually changing revenue outcomes.
Teams are experimenting. Tools are deployed. Efficiency is reported. But when the questions turn to sales cycle compression, competitive timing, and defensibility at the CFO or board level, clarity often breaks down.
For commercial leaders who need to move faster than competitors without increasing regulatory risk, I offer a focused strategic engagement designed to turn AI experimentation into a governed revenue system with clear ownership, measurable impact, and board-ready decision logic.
The Problem
The CFO Red Pen and the Pilot Trap
Most MedTech organizations have already invested in AI. Licenses are purchased. Teams are experimenting. But when leadership asks how those investments are impacting revenue velocity, sales cycles, or market position, the answers are often unclear.
Meanwhile, competitors are moving faster, closing deals in 60 days instead of 90, reaching peak sales quarters ahead of you, and locking in relationships with key oncology practices and top 20 accounts you were also courting.
In a regulated environment, speed without governance creates risk. But without a clear operating framework, AI remains fragmented, underutilized, and vulnerable to budget cuts.
The clock is ticking. And no one owns the outcome.
THE SOLUTION
The AI Moat Plan
The AI Moat Plan is a commercial governance engagement, not a technical implementation. It is designed to help CMOs and CROs move from isolated AI pilots to a coordinated system that delivers measurable revenue impact while maintaining regulatory integrity.
The plan aligns AI adoption across three executive pillars:
Revenue Acceleration
Shorten sales cycles and improve conversion by prioritizing high-propensity opportunities and reducing wasted effort.
Compliance-Safe Scale
Enable personalization and speed without introducing regulatory exposure through clearly defined guardrails and approval flows.
Organizational Leverage
Reallocate team effort away from manual checks and low-value work toward higher-impact physician and account engagement.
What You Receive
Ownership & Accountability Framework
Clear assignment of who owns each AI initiative, how cross-functional alignment will be maintained, and escalation paths for conflicts.
AI ROI & Adoption Assessment
A focused review of current AI usage, license utilization, and where value is being created or lost.
Velocity Roadmap
A clear 90-day plan outlining where AI should be applied, in what sequence, and how impact will be measured
Compliance & Governance Guardrails
Defined operating standards so AI-generated outputs are compliant by design, not retroactively reviewed.
This is a board-ready decision document, not a slide deck.
Most CMOs tell me this is the moment everything clicks.
Why The AI Moat Plan Is Different
This is not an AI initiative. Most AI efforts fail because no one owns the outcome. Teams experiment, but accountability is diffuse. When leadership asks for results, everyone points to someone else.
The AI Moat Plan solves this by doing three things:
1. Assigns clear ownership
We define who owns each AI investment, what success looks like, and how conflicts get resolved. No more political gridlock.
2. Delivers a decision document
You get a board-ready artifact you can present upward. The CFO sees the investment logic. Legal sees the guardrails. Your team sees the roadmap.
3. Measures what matters
We track revenue acceleration, not activity. Sales cycle compression, not license adoption. Competitive positioning, not "time saved."
This is governance that accelerates, not slows down.
The Outcome
Organizations that govern AI effectively do not rely on enthusiasm or experimentation. They gain speed, clarity, and defensibility.
The result is not just efficiency, but a sustained competitive position built on faster execution and safer scale.
You move while competitors pilot. You defend while they justify.
You compound while they catch up.
Start With The AI Moat Plan
A focused strategic engagement for CMOs, CROs, and commercial leaders who need AI decisions to stand up to financial, regulatory, and competitive scrutiny.
What happens next: You'll receive a response within 48 hours. If it's a fit, we'll schedule a 30-minute scoping
call to confirm deliverables and timeline.
If we're not a fit, I'll tell you directly and point you to the right next step.
Who This Is For
This engagement is designed for MedTech commercial leaders who:
Have already invested in AI tools but can't prove revenue impact
Need a defensible plan they can present to the CFO or board
Want to move faster than competitors without increasing compliance risk
Understand that governance creates speed, not friction
Not for:
Companies still deciding whether AI matters, or organizations without budget authority for strategic initiatives.
About
Kathryn E. Nuñez
I build revenue systems in regulated environments where speed and risk are always in tension. 30+ years in medical diagnostics and biotech, spanning hands-on lab operations, oncology sales leadership, clinical trials, and international business development. Built systems across 10+ countries in North America, Latin America, Asia, and Europe.
I've made high-stakes decisions where outcomes mattered. That experience trains calm command. In MedTech, that matters.
When you hire me, you get strategy with precision. No flinching. No chaos. No shortcuts.
Kathryn E. Nuñez
Founder, Revenue Alchemy